Medtronic earnings beat by $0.04, revenue topped estimates

Investing.com – Medtronic (NYSE: ) reported third quarter EPS of $1.30, $0.04 better than the analyst estimate of $1.26. Revenue for the quarter came in at $8.1B versus the consensus estimate of $7.95B.

Guidance

Medtronic sees FY 2024 EPS of $5.19-$5.21 versus the analyst consensus of $5.16.

Medtronic’s stock price closed at $84.42. It is up 6.90% in the last 3 months and down -1.25% in the last 12 months.

Medtronic saw 17 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Medtronic’s stock price’s past reactions to earnings here.

According to InvestingPro, Medtronic’s Financial Health score is “good performance”.

Check out Medtronic’s , and Medtronic’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar